Utilizing Restrictive Opioid Prescribing in Gynecologic Oncology
نویسندگان
چکیده
منابع مشابه
Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients.
OBJECTIVES Blood products are scarce but essential medical resources. Initially transfusions showed increased perioperative complications, prolonged hospitalizations, and higher mortality. Recently developed restrictive transfusion policies have not shown those adverse affects in critically ill patients. Hospitals adopted these policies to guide blood product administration. The objective of th...
متن کاملRobotic Surgery in Gynecologic Oncology
Robotic surgery for the management of gynecologic cancers allows for minimally invasive surgical removal of cancer-bearing organs and tissues using sophisticated surgeon-manipulated, robotic surgical instrumentation. Early on, gynecologic oncologists recognized that minimally invasive surgery was associated with less surgical morbidity and that it shortened postoperative recovery. Now, robotic ...
متن کاملRobotic surgery in gynecologic oncology.
PURPOSE OF REVIEW The objective of this article is to review the recently published literature on the use of robotic surgery in the management of gynecologic malignancies. RECENT FINDINGS Retrospective data collected from many institutions support the use of robotic surgery in the management of cervical, endometrial, and early-stage ovarian cancer. Benefits to robotic surgery include decrease...
متن کاملOpioid Use in Gynecologic Oncology; Balancing Efficacy, Accessibility and Safety: An SGO Clinical Practice Statement.
The problem of opioid misuse has been called an “epidemic” and a “public health crisis” [1]. Though efforts to regulate prescribing practices have focused on non-cancer pain, existing andproposed legislation could significantly impact oncology patients andproviders aswell. Opioids are first line therapy for all but mild cancer pain [2]. Historically the problem with cancer pain has been under t...
متن کاملOncology biomarkers for gynecologic malignancies.
Current therapies efficiently treat most patients with gynecologic malignancies detected at an early stage. Thus, the identification of oncology biomarkers for screening and monitoring of occult tumors has been highly prioritized. Hyperglycosylated human chorionic gonadotropin (hCG) epitomizes oncologic biomarker, as the serum level of this hormone is elevated in virtually all cases of gestatio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncology Times
سال: 2020
ISSN: 0276-2234
DOI: 10.1097/01.cot.0000666588.08420.a0